May 24, 2017 | News Release Review

‘Holy grail of food allergy treatment?’ Food allergies weren’t even part of this 2-person study

The release should have been more clear that this study has significant limitations in both sample size and duration of effect and that nothing is known about whether this effect can be repeated usefully, reliably or safely.

1 Star

New cancer drug can prevent reactions to common airborne allergens

May 23, 2017 | Story Review

Could an expensive chemotherapy drug treat severe asthma? It’s too soon to know

Considering how preliminary this trial is, there’s not a lot of news value to lay readers who are hoping for new asthma treatment options.

4 Star

Could Cancer Drug Gleevec Help With Severe Asthma?

May 23, 2017 | News Release Review

Small pilot study doesn’t warrant bold claim about fennel for menopause symptoms

Although the release includes a cautionary quote at the end calling for further study, the headline is far too optimistic for a small study of brief duration.

3 Star

Study confirms benefits of fennel in reducing postmenopause symptoms

May 22, 2017 | Story Review

Keytruda for bladder cancer: No independent scrutiny of Merck-reported results

Details that patients care about–such as the incredibly steep price tag and potential for adverse effects–didn’t get much attention in this story.

3 Star

Merck says test shows Keytruda improves survival for bladder cancer patients


Tips for Understanding Studies

View More


Story Reviews

Our team of reviewers applies 10 standardized criteria to news stories that include claims about health care interventions. ~2,000 reviews published.

Read More

News Release Reviews

We systematically evaluate the quality of health care-related news releases by journals, medical centers, drug/device makers, others.

Read More


Wide-ranging exploration of issues in journalism, journal publishing, health care PR, advertising and marketing. Some opinions - publisher Gary Schwitzer's & others'.

Read More